| UK Earnings, Trading Statements Calendar | |
| Wednesday, May 6 | |
| Carillion | Interim Management Statement |
| NCC Group | Interim Management Statement |
| GlaxoSmithKline | Q1 Results at 1200 BST |
| CRH | Interim Management Statement |
| DS Smith | Trading Statement |
| Direct Line Insurance Group | Q1 Interim Management Statement |
| Imperial Tobacco Group | Half Year Results |
| IAG | April Traffic Statistics |
| Legal & General Group | Q1 Interim Management Statement |
| J Sainsbury | Full Year Results |
| JD Wetherspoon | Q3 Interim Management Statement |
| Prudential | Q1 Interim Management Statement at 0915 BST |
| Sage Group | Half Year Results |
| Supergroup | Q4 Results |
| National Express | Q1 Interim Management Statement |
| GKN | Interim Management Statement |
| Intu Properties | Trading Statement |
| Inmarsat | Q1 Results |
| Thursday, May 7 | |
| Aviva | Q1 Interim Management Statement |
| Wm Morrison Supermarkets | Interim Management Statement |
| Telecity | Q1 Interim Management Statement |
| Beazley | Q1 Interim Management Statement |
| Esure Group | Q1 Interim Management Statement |
| Millennium & Copthorne Hotels | Q1 Results |
| Provident Financial Group | Interim Management Statement |
| EasyJet | April Traffic Statistics |
| BT Group | Q4 Results |
| RSA Insurance | Q1 Interim Management Statement |
| Trinity Mirror | Trading Statement |
| Kennedy Wilson Europe Real Estate | Q1 Interim Management Statement |
| IMI | Interim Management Statement |
| Friday, May 8 | |
| BG Group | Q1 Results |
| Rolls-Royce | Q1 Interim Management Statement |
| Intercontinental Hotels Group | Q1 Interim Management Statement |
| BBA Aviation | Q1 Interim Management Statement |
| Laird | Interim Management Statement |
| Man Group | Q1 Interim Management Statement |
| Monday, May 11 | |
| Dignity | Q1 Results |
| Diploma | Half Year Results |
| Lonmin | Half Year Results |
| ITE Results | Half Year Results |
| Spirax-Sarco Engineering | Interim Management Statement |
| Nature Group | Full Year Results |
| Tuesday, May 12 | |
| Iofina | Full Year Results |
| Hiscox | Q1 Interim Management Statement |
| JZ Capital Partners | Full Year Results |
| Vitec Group | Full Year Results |
| EasyJet | Half Year Results |
| Experian | Full Year Results |
| Verona Pharma | Full Year Results |
| Enterprise Inns | Half Year Results |
| Speedy Hire | Full Year Results |
| LXB Retail Properties | Half Year Results |
| Copyright 2015 Alliance News Limited. All Rights Reserved. | |
13 Jan 2020 11:08
Verona Pharma shares surge after results from latest study
(Sharecast News) - Respiratory disease-focussed biopharmaceuticals company Verona Pharma announced positive top-line data from a four week, 416 patient phase 2b dose-ranging study evaluating nebulised ensifentrine or placebo as an add-on treatment to 'Spiriva Respimat', or tiotropium, which is a long acting anti-muscarinic bronchodilator, in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).
Read more